Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex

The molecular chaperone Hsp90 modulates the function of specific cell signaling proteins. Although targeting Hsp90 with the antibiotic inhibitor geldanamycin (GA) may be a promising approach for cancer treatment, little is known about the determinants of Hsp90 interaction with its client proteins. Here we identify a loop within the N lobe of the kinase domain of ErbB2 that determines Hsp90 binding. The amino acid sequence of the loop determines the electrostatic and hydrophobic character of the protein's surface, which in turn govern interaction with Hsp90. A point mutation within the loop that alters ErbB2 surface properties disrupts Hsp90 association and confers GA resistance. Notably, the immature ErbB2 point mutant remains sensitive to GA, suggesting that mature and nascent client kinases may use distinct motifs to interact with the Hsp90 chaperone complex.

[1]  K. Arndt,et al.  Identification of a Conserved Sequence Motif That Promotes Cdc37 and Cyclin D1 Binding to Cdk4* , 2004, Journal of Biological Chemistry.

[2]  Z. Xiang,et al.  Extending the accuracy limits of prediction for side-chain conformations. , 2001, Journal of molecular biology.

[3]  Neal Rosen,et al.  Crystal Structure of an Hsp90–Geldanamycin Complex: Targeting of a Protein Chaperone by an Antitumor Agent , 1997, Cell.

[4]  L. Neckers,et al.  Polyubiquitination and Proteasomal Degradation of the p185c-erbB-2 Receptor Protein-tyrosine Kinase Induced by Geldanamycin* , 1996, The Journal of Biological Chemistry.

[5]  A. Citri,et al.  Drug‐induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy , 2002, The EMBO journal.

[6]  S. Uma,et al.  High affinity binding of Hsp90 is triggered by multiple discrete segments of its kinase clients. , 2003, Biochemistry.

[7]  J. Brugge,et al.  Controlled Dimerization of ErbB Receptors Provides Evidence for Differential Signaling by Homo- and Heterodimers , 1999, Molecular and Cellular Biology.

[8]  G. Carpenter,et al.  Geldanamycin Induces ErbB-2 Degradation by Proteolytic Fragmentation* , 2000, The Journal of Biological Chemistry.

[9]  L. Neckers,et al.  p185erbB2 binds to GRP94 in vivo. Dissociation of the p185erbB2/GRP94 heterocomplex by benzoquinone ansamycins precedes depletion of p185erbB2. , 1996, The Journal of biological chemistry.

[10]  D. Toft,et al.  The Assembly and Intermolecular Properties of the hsp70-Hop-hsp90 Molecular Chaperone Complex* , 2002, The Journal of Biological Chemistry.

[11]  T. Yagi,et al.  Induction of a variety of tumors by c‐erbB2 and clonal nature of lymphomas even with the mutated gene (Val659‐‐‐‐Glu659). , 1990, The EMBO journal.

[12]  M. Dowsett,et al.  Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer. , 2001, Endocrine-related cancer.

[13]  L. Neckers,et al.  Hsp90, not Grp94, regulates the intracellular trafficking and stability of nascent ErbB2 , 2002, Cell stress & chaperones.

[14]  Cinque S. Soto,et al.  Evaluating conformational free energies: The colony energy and its application to the problem of loop prediction , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Paul Workman,et al.  Activation of the ATPase activity of hsp90 by the stress-regulated cochaperone aha1. , 2002, Molecular cell.

[16]  Y. Yarden,et al.  Sensitivity of Mature ErbB2 to Geldanamycin Is Conferred by Its Kinase Domain and Is Mediated by the Chaperone Protein Hsp90* , 2001, The Journal of Biological Chemistry.

[17]  L. Pearl,et al.  Regulation of Hsp90 ATPase Activity by the Co-chaperone Cdc37p/p50 cdc37 * , 2002, The Journal of Biological Chemistry.

[18]  Y. Miyata,et al.  CK2 Controls Multiple Protein Kinases by Phosphorylating a Kinase-Targeting Molecular Chaperone, Cdc37 , 2004, Molecular and Cellular Biology.

[19]  M. Sliwkowski,et al.  Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor* , 2002, The Journal of Biological Chemistry.

[20]  T. Tsuruo,et al.  Modulation of Akt kinase activity by binding to Hsp90. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Matts,et al.  Phosphorylation of Serine 13 Is Required for the Proper Function of the Hsp90 Co-chaperone, Cdc37* , 2003, Journal of Biological Chemistry.

[22]  A. Marrogi,et al.  p53, c-erbB2, and PCNA status in benign, proliferative and malignant ovarian surface epithelial neoplasms: a study of 75 cases. , 1999, Archives of pathology & laboratory medicine.

[23]  L. Neckers,et al.  Heat shock protein 90 as a molecular target for cancer therapeutics. , 2003, Cancer cell.

[24]  R. Matts,et al.  Functional dissection of cdc37: characterization of domain structure and amino acid residues critical for protein kinase binding. , 2003, Biochemistry.

[25]  B. Honig,et al.  An integrated approach to the analysis and modeling of protein sequences and structures. III. A comparative study of sequence conservation in protein structural families using multiple structural alignments. , 2000, Journal of molecular biology.

[26]  B. Honig,et al.  On the role of structural information in remote homology detection and sequence alignment: new methods using hybrid sequence profiles. , 2003, Journal of molecular biology.

[27]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[28]  M. Galigniana,et al.  Visualization and Mechanism of Assembly of a Glucocorticoid Receptor·Hsp70 Complex That Is Primed for Subsequent Hsp90-dependent Opening of the Steroid Binding Cleft* , 2003, Journal of Biological Chemistry.

[29]  M. Hung,et al.  Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells. , 1991, Oncogene.

[30]  Chrisostomos Prodromou,et al.  Structural and functional analysis of the middle segment of hsp90: implications for ATP hydrolysis and client protein and cochaperone interactions. , 2003, Molecular cell.

[31]  G. Merlino,et al.  Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  P. Miller,et al.  Depletion of the erbB-2 gene product p185 by benzoquinoid ansamycins. , 1994, Cancer research.

[33]  Noah Craft,et al.  A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase , 1999, Nature Medicine.

[34]  S. Jackson,et al.  Stimulation of the weak ATPase activity of human hsp90 by a client protein. , 2002, Journal of molecular biology.

[35]  G. Carpenter,et al.  Identification of ErbB-2 kinase domain motifs required for geldanamycin-induced degradation. , 2003, Cancer research.

[36]  L. Neckers,et al.  The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[37]  R. Kumar,et al.  The role of HER2 in angiogenesis. , 2001, Seminars in oncology.

[38]  W. Pratt,et al.  Regulation of Signaling Protein Function and Trafficking by the hsp90/hsp70-Based Chaperone Machinery 1 , 2003, Experimental biology and medicine.

[39]  R. Hartmann-Petersen,et al.  Transferring substrates to the 26S proteasome. , 2003, Trends in biochemical sciences.

[40]  Wei Zhang,et al.  Biochemical and structural studies of the interaction of Cdc37 with Hsp90. , 2004, Journal of molecular biology.

[41]  S. Aaronson,et al.  Implications for Cancer Therapy , 2003 .

[42]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[43]  Timothy A. J. Haystead,et al.  The Amino-terminal Domain of Heat Shock Protein 90 (hsp90) That Binds Geldanamycin Is an ATP/ADP Switch Domain That Regulates hsp90 Conformation* , 1997, The Journal of Biological Chemistry.